Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints

Clinical Orthopaedics and Related Research

Volumn 352, Issue , 1998, Pages 35-45

  Takagi, Michiaki ^a   Santavirta, Seppo ^b   Ida, Hideo ^a   Ishii, Masaji ^c   Mandelin, Jami ^d   Konttinen, Yrjö T ^d  

^a YAMAGATA UNIVERSITY   (Japan)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Saiseikai Yamagata Hospital   (Japan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; ELASTASE; GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; STROMELYSIN;

CONFERENCE PAPER; ENZYME INHIBITION; ENZYME REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; FOREIGN BODY REACTION; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROSTHESIS LOOSENING; TOTAL HIP PROSTHESIS;

EID: 0031866041     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (100)

1. Aimes RT, Quigley JP: Matrix metalloproteinase-2 is an interstitial collagenase. J Biol Chem 270: 5872-5876, 1995.
2. Apte SS, Olsen BR, Murphy G: The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 270:14313-14318, 1995.
3. Azzo W, Woessner Jr JF: Purification and characterization of an acid metalloproteinase from human articular cartilage. J Biol Chem 261:5434-5441, 1986.
4. Basset P, Bellocq JP, Wolf C, et al: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704, 1990.
5. Birkedal-Hansen H: Role of matrix metalloproteinases in human periodontal disease. J Periodotol 64:474-484, 1993.
6. Birkedal-Hansen H: Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 28:500-510, 1993.
7. Birkedal-Hansen H, Moore WGI, Bodden MK, et al: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197-250, 1993.
8. Birkedal-Hansen H, Taylor RE, Zambon JJ, et al: Characterization of collagenase activity from strains of Bacterioides gingivalis. J Periodontal Res 23: 258-264, 1988.
9. Bode W: A helping hand for collagenase: The hemopexin-like domain (review). Structure 3:527-530, 1995.
10. Boone TC, Johnson MJ, De Clerck YA, Langley KE: cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci USA 87: 2800-2804, 1990.
11. Carmichael DF, Sommer A, Thompson RC, et al: Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA 83:2407-2411, 1986.
12. Cawston TE, Murphy G, Mercer E, et al: The interaction of purified rabbit bone metalloproteinases inhibitor. Biochem J 211:313-318, 1983.
13. Chambers TJ, Darby JA, Fuller K: Mammalian collagenase predispose bone surface to osteoclastic bone resorption. Cell Tissue Res 241:671-675, 1985.
14. Collier IE, Wilhelm SM, Eisen AZ: H-ras oncogene transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 263:6579-6587, 1988.
15. Cossins J, Dudgeon TJ, Catlin G, Gearing AJH, Clements JM: Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem Biophys Res Comm 228:494-498, 1996.
16. Drake FH, Dodds RA, James IE, et al: Cathepsin K, but not Cathepsin B, L, or S, is abundantly expressed in human osteoclast. J Biol Chem 271:12511-12516, 1996.
17. Feng DF, Doolittle RF: Progressive sequence alignment as prerequisite to correct phylogenetic trees. J Mol Evol 25:351-360, 1987.
18. Freiji JMP, Diez-Itza I, Balbin M, et al: Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269:16766-16773, 1994.
19. Gelb BD, Shi GP, Chapman HA, Desnick RJ: Pychnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-1238, 1996.
20. Goldberg GI, Manner BL, Grant GA, et al: Human 72 kDa type IV collagenases forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2. Proc Natl Acad Sci USA 86:8207-8211, 1989.
21. Goldberg GI, Wilhelm SM, Kronberger A, et al: Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261:6600-6605, 1986.
22. Goldring SR, Jasty M, Roelke MS, et al: Formation of the synovial-like membrane at the bone cement interface: Its role in bone resorption and implant loosening after total hip replacement. Arthritis Rheum 29:836-842, 1986.
23. Goldring SR, Schiller AL, Roelke M, et al: The synovial-like membrane at the bone cement interface in loose total hip replacement and its proposed role in bone lysis. J Bone Joint Surg 65A:575-584, 1983.
24. Gooley PR, O'Connel JF, Marcy AI, et al: The NMR structure of the inhibited catalytic domain of human stromelysin-1. Nature Structural Biology 1:111-118, 1994.
25. Greene J, Wang M, Liu YE, et al: Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271:30375-30380, 1996.
26. Hanemaajier R, Sorsa T, Konttinen YT, et al: Expression and regulation of matrix metalloproteinase-8 in synovial fibroblasts and endothelial cells. J Biol Chem 272:31504-31509, 1997.
27. Harris WH, Schiller AL, Scholler JM, et al: Extensive localized bone resorption in the femur following total hip replacement. J Bone Joint Surg 58A:612-618, 1976.
28. Hasty KA, Pourmotabbed TF, Goldberg GI, et al: Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 265:11421-11424, 1990.
29. Haynes DR, Rogers SD, Hay S, Pearcy MJ, Howie DW: The differences in toxicity and release of bone-resorbing mediators induced by titanium and cobalt-chromium-alloy wear particles. J Bone Joint Surg 75A:825-834, 1993.
30. Higgins DG, Sharp PM: Fast and sensitive multiple sequence alignment on a microcomputer. Comput Appl Biosci 5:151-153, 1989.
31. Hill PA, Murphy G, Docherty AJ, et al: The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci 107:3055-3064, 1994.
32. Holliday LS, Welgus HG, Fliszar CJ, et al: Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 272:22053-22058, 1997.
33. Horowitz SM, Doty SB, Lane JM, Burstein AH: Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption. J Bone Joint Surg 75A:802-813, 1993.
34. Howard EW, Bullen EC, Banda MJ: Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinase-2. J Biol Chem 266:13070-13075, 1991.
35. Howie DW, Haynes DR, Rogers SD, McGee MA, Pearcy MJ: The response to particulate debris (review). Orthop Clin North Am 24:571-581, 1993.
36. Imai S, Konttinen YT, Jumppanen, et al: High level of expression of collagenase-3 (MMP-13) in pathological conditions associated to a foreign body reaction. J Bone Joint Surg 1998 (In Press).
37. Ishiguro N, Ito T, Kurokouchi K, et al: mRNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in interface tissue around implants in loosening total hip arthroplasty. J Biomed Mater Res 32:611-617, 1996.
38. Jasty M, Maloney WJ, Bragdon CR, Haire T, Harris WH: Histomorphological studies of the long term skeletal response to well fixed cemented femoral components. J Bone Joint Surg 72A:1220-1229, 1990.
39. Jiranek WA, Machado M, Jasty M, et al: Production of cytokines around loosened cemented acetabular components. J Bone Joint Surg 75A:863-879, 1993.
40. Kim KJ, Rubash H, Wilson SC, D'Antonio JA, McClain EJ: A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop 287:142-152, 1993.
41. Knäuper V, Will H, Lopez-Otin C, et al: Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 271:17124-17131, 1996.
42. Konttinen YT, Imai S, Suda A: State of the art: Bone neuropeptides and the bone remodeling. Acta Orthop Scand 67:632-639, 1996.
43. Konttinen YT, Kurvinen H, Takagi M, et al: IL-1 and collagenase around loose total hip prosthesis. Clin Exp Rheumatol 14:255-262, 1996.
44. Konttinen YT, Xu J-W, Pätiälä H, et al: Cytokines in aseptic loosening of total hip replacement. Curr Orthop 11:40-47, 1997.
45. Kyte J, Doolittle RF: A single method for displaying the hydropathic character of a protein. J Mol Biol 157:105-132, 1982.
46. Laitala T, Väänänen HK: Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two sub-units of vacuolar H+-ATPase. J Clin Invest 93:2311-2318, 1994.
47. Lauhio A, Sorsa T, Lindy O, et al: The anti-inflammatory potential of lymecycline in long-term treatment of reactive arthritis. Arthritis Rheum 35:195-198, 1992.
48. Li J, Brick P, O'Hare MC, et al: Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure 3:541-549, 1995.
49. Lindy O, Konttinen YT, Sorsa T, et al: Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 40:1391-1399, 1997.
50. Liu YE, Wang M, Greene J, et al: Preparation and characterization of recombinant tissue inhibitor of metalloproteinases 4 (TIMP-4). J Biol Chem 272:20479-20483, 1997.
51. Malone JD, Teitelbaum SL, Griffin GL, Senior RM, Kahn AJ: Recruitment of osteoclast precursors by purified bone matrix components. J Cell Biol 92:227-230, 1982.
52. Maloney WJ, Smith RL, Castro F, Schurman DJ: Fibroblast response to metallic debris in vitro. Enzyme induction, cell proliferation and toxicity. J Bone Joint Surg 75A:835-844, 1993.
53. Mordian-Oldak J, Sarte PE, Fincham AG: Description of proteinase from enamel extracellular matrix cleaving a recombinant amelogenin. Connect Tissue Res 35:231-238, 1996.
54. Müller D, Quantin B, Gesnel MC, et al: The collagenase gene family in humans consists of at least four members. Biochem J 253:187-192, 1988.
55. Nagase H: Activation mechanism of matrix metalloproteinases (review). Biol Chem 378:151-160, 1997.
56. Nakano T, Scott P: Partial purification and characterization of a neutral proteinase with collagen telopeptidase activity produced by human gingival fibroblasts. Biochem Cell Biol 65:286-292, 1987.
57. Ohuchi E, Imai K, Fujii Y, et al: Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix molecules. J Biol Chem 272:2446-2451, 1997.
58. Okada Y, Gonojo Y, Naka K, et al: Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem 267:21712-21719, 1992.
59. Ovaerall CM, Sodek J: Initial characterization of a neutral metalloproteinase, active on native 3/4-collagen fragments, synthesized by ROS 17/2.8 osteoblastic cells, periodontal fibroblasts, and identified in gingival crevicular fluid. J Dent Res 66:1271-1282, 1987.
60. Pavloff N, Staskus PW, Kishinami NS, Hawkes SP: A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of TIMP family. J Biol Chem 267:17321-17326, 1992.
61. Pei D, Weiss SJ: Transmembrane-deletion mutants of the membrane type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix degrading activity. J Biol Chem 271:9135-9140, 1994.
62. Pendas AM, Knäuper V, Puente XS, et al: Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 272:4281-4286, 1997.
63. Polette M, Nawrocki B, Gilles C, et al: MT-MMP expression and localization in human lung and breast cancers. Virchows Arch 428:29-35, 1996.
64. Puente XP, Pendas AM, Llano E, Velasco G, Lopez-Otin C: Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56:944-949, 1996.
65. Saari H: Reactive Oxygen Species as Mediators of Tissue Destruction Events in Inflammatory Joint Diseases. PhD Thesis. Helsinki, University of Helsinki, 1992.
66. Sato H, Seiki M: Regulatory mechanism of 92 kD type IV collagenases gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395-405, 1993.
67. Sato H, Takino T, Okada Y, et al: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65, 1994.
68. Santavirta S, Ceponis A, Solovieva SA, et al: Periprosthetic microvasculature in loosening of total hip prostheses. Arch Orthop Trauma Surg 115:286-289, 1996.
69. Santavirta S, Konttinen YT, Bergroth V, et al: Aggressive granulomatous lesions associated with hip arthroplasty: Immunopathological studies. J Bone Joint Surg 72A:252-258, 1990.
70. Santavirta S, Konttinen YT, Hoikka V, Eskola A: Immunopathological response to loose cementless acetabular components. J Bone Joint Surg 73B:38-42, 1991.
71. Santavirta S, Sorsa T, Konttinen YT, et al: Role of mesenchymal collagenase in the loosening of total hip prostheses. Clin Orthop 290:206-215, 1993.
72. Shapiro SD, Griffin GL, Gillbert DJ, et al: Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem 267:4664-4671, 1992.
73. Sorsa T, Salo T, Koivunen E, et al: Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem 272:21067-21074, 1997.
74. Spurlino JC, Smallwood AM, Carlton DD, et al: A structure of mature truncated human fibroblast collagenase. Proteins 19:98-109, 1994.
75. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP)-2. J Biol Chem 264:17374-17378, 1989.
76. Stricklin GP, Welgus HG: Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J Biol Chem 258:12252-12258, 1983.
77. Strongin AY, Collier I, Bannikov G, et al: Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J Biol Chem 270:5331-5338, 1995.
78. Suomalainen K, Sorsa T, Golub LM, et al: Specificity of the anti-collagenase action of tetracycline: Relevance to their anti-inflammatory potential. Antimicrob Agents Chemother 36:227-229, 1992.
79. Takagi M: Neutral proteinases and their inhibitors in the loosening of total hip prostheses (review). Acta Orthop Scand 67 (Suppl 271):1-29, 1996.
80. Takagi M, Konttinen YT, Kemppinen P, et al: Tissue inhibitor of matrix metalloproteinases-1 and collageno- and gelatinolytic potential in loose THR endoprostheses. J Rheumatol 22:2285-2290, 1995.
81. Takagi M, Konttinen YT, Lindy O, et al: Gelatinase/type IV collagenases in the loosening of total hip replacement endoprosthesis. Clin Orthop 306:136-144, 1994.
82. Takagi M, Konttinen YT, Santavirta S, et al: Matrix Metalloproteinases and Serine Proteinases in Loosening of Endoprosthesis. In Machtey I (ed). Progress in Rheumatology 5. Petach-Tiqva, Israel, Rheumatology Service, Hasharon Hospital, Golda Medical Center 26-31, 1993.
83. Takagi M, Konttinen YT, Santavirta S, et al: Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand 65:281-286, 1994.
84. Takagi M, Konttinen YT, Santavirta S, et al: Cathepsin G and alpha-1 antichymotrypsin in the local host reaction to loosening of total hip prostheses. J Bone Joint Surg 77A:16-25, 1995.
85. Takagi M, Konttinen YT, Santavirta S, et al: Elastase activity, uninhibited by alpha-1 antitrypsin, in the periprosthetic connective tissue matrix around total hip prostheses. J Orthop Res 13:296-304, 1995.
86. Takagi M, Santavirta S, Ida H, et al: Role of Matrix Metalloproteinases in Periprosthetic Connective Tissue Remodeling in Loose THA Implants. In Imura S (ed). Joint Arthroplasty. Tokyo, Springer-Verlag (In Pess).
87. Takagi M, Santavirta A, Ida H, et al: MI-1 MMP/MMP-2/TIMP-2 system in periprosthetic connective tissue remodeling in loose total hip prostheses. Lab Invest (In Press).
88. Takagi M, Santavirta S, Konttinen YT, et al: Proteolytic Potential of Matrix Metalloprotemases and Serine Proteinases in the Host Response to THR Endoprostheses. In Andersson H, Happonen RP (eds). Bioceramics 7. Oxford, Butterworth-Heimann Ltd 311-316, 1994.
89. Takino T, Sato H. Shinagawa A, Seiki M: Identification of the second membrane type matrix metalloproteinase (MT-MMP-2) gene from human placenta cDNA library. J Biol Chem 270: 23013-23020, 1995.
90. Teronen O, Konttinen YT, Lindqvist C, et al: Human neutrophil collagenase MMP-8 in periimplant sulcus fluid and its inhibition by clodronate. J Dent Res 76:1529-1537, 1997.
91. Teronen O, Konttinen YT, Lindqvist C, et al: Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphanate (clodronate). Calcif Tissue Int 61:59-61, 1997.
92. Tezuka K, Nemoto K, Tezuka Y, et al: Identification of matrix metalloproteinase 9 in rabbit osteoclast. J Biol Chem 269:15006-15009, 1994.
93. Väänänen HK. Mechanism of bone turnover. Ann Med 25:353-359, 1993.
94. Werb Z. Proteinases and Matrix Degradation. In Kelly WB, Harris Jr ED, Rubby S, Sledge CB (eds). Textbook of Rheumatology. Ed 3. Philadelphia, WB Saunders 300-321, 1989.
95. Wick M, Burger C, Brusselbach S, Lucibello FC, Muller R: A novel member of human tissue inhibitor of metalloproteinase (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation and senescence. J Biol Chem 269:18953-18960, 1994.
96. Wilhelm SM, Collier IE, Kronberger A, et al: Human skin fibroblast stromelysin: Structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci USA 84:6725-6729, 1987.
97. Wilhelm SM, Collier IE, Marmer BL, et al: SV 40-transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 26:17213-17221, 1989.
98. Will H, Hinzmann B: cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231:602-608, 1995.
99. Woessner Jr JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154, 1991.
100. Yokohama Y, Matsumoto T, Hirakawa M, et al: Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements. Lab Invest 72:899-911, 1995.